Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.96 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.96 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.96 |
| ▸ | MAPT | P10636 | 2/20 | 0.96 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.96 |
| ▸ | TSHR | P16473 | 1/20 | 0.96 |
| ▸ | BLM | P54132 | 1/20 | 0.96 |
| ▸ | AGER | Q15109 | 1/20 | 0.96 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.96 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.96 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | ASPH | Q12797 | 2/20 | 0.52 |
| ▸ | KDM8 | Q8N371 | 2/20 | 0.52 |
| ▸ | DHODH | Q02127 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quinolinic Acid SCHEMBL343618 | 0.98 | KDM4E (1.00) | KDM4EALDH1A1ALOX15MAPTCYP3A4 | |
| Quinolinic Acid SCHEMBL69230 | 0.98 | KDM4E (1.00) | KDM4EALDH1A1ALOX15MAPTCYP3A4 | |
| Quinolinic Acid SCHEMBL27676801 | 0.98 | KDM4E (1.00) | KDM4EALDH1A1ALOX15MAPTCYP3A4 | |
| Quinolinic Acid SCHEMBL29356188 | 0.98 | KDM4E (1.00) | KDM4EALDH1A1ALOX15MAPTCYP3A4 | |
| Quinolinic Acid SCHEMBL5361020 | 0.96 | KDM4E (0.96) | KDM4EALDH1A1ALOX15MAPTCYP3A4 | |
| Quinolinic Acid SCHEMBL3744925 | 0.96 | KDM4E (0.96) | KDM4EALDH1A1ALOX15MAPTCYP3A4 | |
| Quinolinic Acid SCHEMBL5674125 | 0.96 | KDM4E (0.96) | KDM4EALDH1A1ALOX15MAPTCYP3A4 | |
| Quinolinic Acid SCHEMBL21326209 | 0.96 | KDM4E (0.96) | KDM4EALDH1A1ALOX15MAPTCYP3A4 | |
| Quinolinic Acid SCHEMBL890367 | 0.96 | KDM4E (0.96) | KDM4EALDH1A1ALOX15MAPTCYP3A4 | |
| Quinolinic Acid SCHEMBL5381551 | 0.96 | KDM4E (0.96) | KDM4EALDH1A1ALOX15MAPTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117986601-A | Vanadium 1, 4-naphthalene dicarboxylic acid coordination polymer and preparation method and application thereof | 合肥通用机械研究院有限公司 | 2024-05-07 | — | — | CN | disclosed |
| EP-2496565-B1 | Process for preparing divinylarene dioxides | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-08-13 | — | — | EP | disclosed |
| US-8716503-B2 | Process for preparing divinylarene dioxides | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-05-06 | — | — | US | disclosed |
| EP-2496565-A1 | PROCESS FOR PREPARING DIVINYLARENE DIOXIDES | Dow Global Technologies LLC (US) | 2012-09-12 | — | — | EP | disclosed |
| US-20120209015-A1 | PROCESS FOR PREPARING DIVINYLARENE DIOXIDES | BLUE CUBE IP LLC | 2012-08-16 | — | — | US | disclosed |
| WO-2011056381-A1 | PROCESS FOR PREPARING DIVINYLARENE DIOXIDES | 1/6DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120209015-A1 | PROCESS FOR PREPARING DIVINYLARENE DIOXIDES | SCO2, PPOX, SQLE | KDM4E 1567/4885ALDH1A1 1769/4885ALOX15 123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.